<- Go Home

Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, pigs, dogs, and cats. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.

Market Cap

EUR 861.1M

Volume

4.0K

Cash and Equivalents

EUR 181.5M

EBITDA

EUR 102.6M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 308.2M

Profit Margin

57.89%

52 Week High

EUR 96.00

52 Week Low

EUR 63.60

Dividend

N/A

Price / Book Value

1.51

Price / Earnings

14.32

Price / Tangible Book Value

2.38

Enterprise Value

EUR 697.4M

Enterprise Value / EBITDA

6.41

Operating Income

EUR 78.4M

Return on Equity

10.79%

Return on Assets

6.84

Cash and Short Term Investments

EUR 181.5M

Debt

EUR 17.7M

Equity

EUR 567.5M

Revenue

EUR 532.4M

Unlevered FCF

EUR 44.3M

Sector

Pharmaceuticals

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches